Clinical Trials
35 trialsNatural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
National Institutes of Health Clinical Center (CC)
Natural History Study of GATA2 Deficiency and Related Disorders
National Institutes of Health Clinical Center (CC)
Natural History Study of Early Life Exposures in Agriculture (ELEA)
National Institutes of Health Clinical Center (CC)
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
National Institutes of Health Clinical Center (CC)
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
National Institutes of Health Clinical Center (CC)
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
National Institutes of Health Clinical Center (CC)
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
National Institutes of Health Clinical Center (CC)
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
National Institutes of Health Clinical Center (CC)
Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
National Institutes of Health Clinical Center (CC)
Case-Control Study of Pesticides and Childhood Leukemia
National Institutes of Health Clinical Center (CC)
Validating Pain Scales in Children and Young Adults
National Institutes of Health Clinical Center (CC)
A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China
National Institutes of Health Clinical Center (CC)
Study of Lymphoma in Asia
National Institutes of Health Clinical Center (CC)
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
National Institutes of Health Clinical Center (CC)
Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Via Cognitive Interviewing and Usability Testing
National Institutes of Health Clinical Center (CC)
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
National Institutes of Health Clinical Center (CC)
Early Life Exposures in Agriculture
National Institutes of Health Clinical Center (CC)
Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident
National Institutes of Health Clinical Center (CC)
Feasibility of Identifying a Chinese Study Population and Eligible Pediatric Cancer Cases, and Linking the Two Groups to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer.
National Institutes of Health Clinical Center (CC)
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
National Institutes of Health Clinical Center (CC)
Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease
National Institutes of Health Clinical Center (CC)
Pharmacokinetic Studies Participation Survey
National Institutes of Health Clinical Center (CC)
Informed Consent in Pediatric Cancer Trials
National Institutes of Health Clinical Center (CC)
CCLS
National Institute of Environmental Health Sciences (NIEHS)
Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant
National Cancer Institute (NCI)
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment
National Cancer Institute (NCI)
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J
National Institutes of Health Clinical Center (CC)
Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998
National Cancer Institute (NCI)
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
National Cancer Institute (NCI)
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
National Institutes of Health Clinical Center (CC)
Evaluation and Natural History of Children With Cancer and AIDS
National Institutes of Health Clinical Center (CC)
Brain Neoplasms, Leukemia and Petrochemical Exposures
National Institute of Environmental Health Sciences (NIEHS)
Protection Against Benzene Toxicity
National Institute of Environmental Health Sciences (NIEHS)